Latest neurological disorders Stories

The development of children with Autism Spectrum Disorder (ASD) is much like that of children without ASD at 6 months of age, but differs afterwards. That's the main finding of the largest prospective, longitudinal study to date comparing children with early and later diagnosis of ASD with children without ASD. The study appears in the journal Child Development and has implications for clinical work, public health, and policy. The study was conducted by researchers at the Kennedy Krieger...

University of Southern Mississippi graduate student has recently been recognized by the the Journal of Biological Chemistry for his research on the formation of toxic agents in the brain in relation to the onset of Alzheimer’s disease in a patient. Kumar’s findings were published in a recent issue of the weekly peer-reviewed scientific journal, which reaches a global audience. Hattiesburg, MS (PRWEB) October 23, 2012 Ahmit Kumar, a fifth-year graduate student at The University of...

RYE, N.Y., Oct. 23, 2012 /PRNewswire/ -- Curemark founder and CEO Dr. Joan Fallon will moderate a panel on neurodegeneration including sessions on autism and schizophrenia at the Phaciliate CNS Leaders Forum, to be held Nov. 5-7 in Boston at the Seaport Hotel. The forum will bring together senior R&D and business executives driving the development and launch of novel drugs for neurodegenerative diseases, psychiatric disorders and pain. Curemark, a drug research and...

CAMBRIDGE, Mass., Oct. 17, 2012 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. announced today positive data with NPT001 in an alpha-synuclein pre-clinical model for Parkinson's disease (PD). The study was funded by The Michael J. Fox Foundation (MJFF). NPT001 is a first-in-class drug candidate with potential disease-modifying activity that disrupts and clears a variety of amyloid aggregates in the brain. In addition to reducing beta amyloid and tau aggregates in Alzheimer's...

Changes in the structure of proteins can lead to various diseases, such as Alzheimer’s, type 2 diabetes and corneal dystrophy. A research team from Aarhus University has now discovered how a particular protein can damage cells. These results may lead to the development of drugs to treat corneal dystrophy in the future. Many diseases are caused by proteins losing their natural three-dimensional structure and thus their function. In most cases, the damaged proteins are degraded by...

NEW HAVEN, Conn., Oct. 15, 2012 /PRNewswire/ -- Prometheus Research, a leading provider of integrated data management services for behavioral and biomedical research, announced today that it has been selected by the University of Missouri to support the data management initiatives of their Thompson Center for Autism and Neurodevelopmental Disorders. Prometheus Research will leverage the technology already in place from their mutual involvement in the Simons Simplex Collection (SSC)...

April Flowers for redOrbit.com - Your Universe Online Motion sickness can affect nearly anyone, in a variety of situations from car rides to amusement park attractions to airplanes. Astronauts often find themselves experiencing motion sickness in space. To combat motion sickness, NASA developed a fast-acting nasal spray that will now be developed and commercialized due to an agreement signed between NASA's Johnson Space Center and Epiomed Therapeutics Inc. Epiomed will formulate the...

Study by Kennedy Krieger's Interactive Autism Network finds children with autism are four times more likely to wander than their unaffected siblings BALTIMORE, Oct. 8, 2012 /PRNewswire-USNewswire/ -- A new study published today in the journal Pediatrics (Epub ahead of print) found that nearly half of children with autism spectrum disorders (ASD) are reported to wander or "bolt," and more than half of these children go missing. Led by researchers from the Interactive Autism Network...

Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them. The discovery reveals a small set of target genes that could be used to measure the health of motor neurons, and provides a useful tool for development of new pharmaceuticals to treat the...

Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible. RDP is caused by a genetic mutation (ATP1A3) that often runs in families. Now Wake Forest Baptist Medical Center researchers believe that...